Fig. 3

Distribution and frequency of type and number of lung lesions in tuberculosis patients with dysglycemia. a Stratification of patients with 1, 2 and 3 types of lung lesions and patients with the number of lung lesions ≥4. b Distribution of types of lung lesions (upper panel) and number of lung lesions ≥4 (lower panel) between the TB and TBGMD groups (C) Frequency of bilateral lesions in patients classified in TB and TBGMD (upper panel) or in those classified in TBPDM and TB-DM (lower panel). In b and c, data were compared between the groups using the Fisher’s exact test (2 × 2 comparisons) or the Pearson’s chi-square test (> 2 groups). TB: tuberculosis, GMD: glucose metabolism disorders, DM: diabetes mellitus PDM: prediabetes, FPG: Fasting plasma glucose, HbA1c: glycated hemoglobin, OGTT: oral glucose tolerance test. One type lesion: cavity (CV) or infiltrate (IN) or fibrous tract (FT); 2 lesion types: CV + IN or CV + FT or IN + FT; 3 lesion types: CV + IN + FT. Number of lung lesions ≥4: considering the total number of cavities + total number of infiltrates + total number of fibrous tracts. Only comparisons with significant p-values are displayed (*p < 0.05, **p < 0.01, ***p < 0.001)